
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 953 | 953 | 844 | 824 | 1285 | 1740 |
Fund Return | -4.67% | -4.67% | -15.57% | -6.26% | 5.15% | 5.7% |
Place in category | 435 | 435 | 437 | 385 | 335 | 54 |
% in Category | 97 | 97 | 100 | 99 | 95 | 21 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Europe EUR Z Acc | 4.43B | 6.79 | 6.04 | 9.46 | ||
Europe EUR I Acc | 4.43B | -2.27 | 3.65 | 7.69 | ||
World EUR R Acc | 856.61M | 4.94 | 7.85 | 9.64 | ||
Greater Europe Opportunities EUR I | 419.36M | 6.27 | -3.34 | 8.26 | ||
Greater Europe Opportunities EUR R | 419.36M | 6.18 | -4.30 | 7.18 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Greater Europe Opportunities EUR R | 419.36M | 6.18 | -4.30 | 7.18 | ||
Greater Europe Opportunities EUR I | 419.36M | 6.27 | -3.34 | 8.26 | ||
LINGOHR-EUROPA-SYSTEMATIC-INVEST | 56.04M | 6.16 | 6.86 | 3.67 | ||
Aramea Aktien Select | 39.03M | 8.08 | 4.84 | 3.20 | ||
CHOM CAPITAL Active Return Europe I | 8.02M | 1.51 | -1.48 | 1.71 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
London Stock Exchange | GB00B0SWJX34 | 6.11 | 11,165.0 | -0.31% | |
Adyen | NL0012969182 | 5.81 | 1,330.60 | -1.67% | |
ASML Holding | NL0010273215 | 5.48 | 577.30 | -0.05% | |
Capgemini | FR0000125338 | 4.62 | 124.60 | -0.52% | |
AstraZeneca | GB0009895292 | 4.49 | 10,008.0 | -0.10% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Strong Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review